Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam Cream in Burn Patients With Induced Dermal Incisions
NCT04685577Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jul 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nefopam in Hypertrophic Scar (HS), sponsored by University of Alberta. Started Jul 2022; status: completed.
02
Drugs
nefopam
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT04685577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04685577.